Abstract |
An enhanced production of IL-1beta in glia is a typical feature of epileptogenic tissue in experimental models and in human drug-refractory epilepsy. We show here that the selective inhibition of Interleukin Converting Enzyme ( ICE), which cleaves the biologically active form of IL-1beta using VX-765, blocks kindling development in rats by preventing IL-1beta increase in forebrain astrocytes, without interfering with glia activation. The average afterdischarge duration was not altered significantly by VX-765. Up to 24 h after kindling completion and drug washout, kindled seizures could not be evoked in treated rats. VX-765 did not affect seizures or afterdischarge duration in fully kindled rats. These data indicate an antiepileptogenic effect mediated by ICE inhibition and suggest that specific anti-IL-1beta pharmacological strategies can be envisaged to interfere with epileptogenic mechanisms.
|
Authors | Teresa Ravizza, Francesco Noé, Daniela Zardoni, Valentina Vaghi, Marco Sifringer, Annamaria Vezzani |
Journal | Neurobiology of disease
(Neurobiol Dis)
Vol. 31
Issue 3
Pg. 327-33
(Sep 2008)
ISSN: 1095-953X [Electronic] United States |
PMID | 18632279
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Anticonvulsants
- Caspase Inhibitors
- Dipeptides
- Enzyme Inhibitors
- Interleukin-1beta
- para-Aminobenzoates
- belnacasan
- Caspase 1
- 4-Aminobenzoic Acid
|
Topics |
- 4-Aminobenzoic Acid
(pharmacology, therapeutic use)
- Animals
- Anticonvulsants
(pharmacology, therapeutic use)
- Astrocytes
(drug effects, metabolism)
- Caspase 1
(metabolism)
- Caspase Inhibitors
- Dipeptides
(pharmacology, therapeutic use)
- Disease Models, Animal
- Enzyme Inhibitors
(pharmacology, therapeutic use)
- Epilepsy
(drug therapy, physiopathology)
- Interleukin-1beta
(biosynthesis, metabolism)
- Kindling, Neurologic
(drug effects, metabolism)
- Male
- Prosencephalon
(drug effects, physiopathology)
- Rats
- Rats, Sprague-Dawley
- para-Aminobenzoates
|